Galdiero M - Search Results

1

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A. Pivonello R, et al. Among authors: galdiero m. Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7. Pituitary. 2017. PMID: 28224405 Review.

2

The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues.

De Martino MC, Auriemma RS, Brevetti G, Vitale G, Schiano V, Galdiero M, Grasso L, Lombardi G, Colao A, Pivonello R. De Martino MC, et al. Among authors: galdiero m. J Endocrinol Invest. 2010 Oct;33(9):663-70. doi: 10.1007/BF03346667. Epub 2010 Jul 1. J Endocrinol Invest. 2010. PMID: 20595800 Clinical Trial.

3

Acromegaly and the cardiovascular system.

Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A. Lombardi G, et al. Among authors: galdiero m. Neuroendocrinology. 2006;83(3-4):211-7. doi: 10.1159/000095530. Neuroendocrinology. 2006. PMID: 17047385 Review.

4

Medical consequences of acromegaly: what are the effects of biochemical control?

Colao A, Auriemma RS, Pivonello R, Galdiero M, Lombardi G. Colao A, et al. Among authors: galdiero m. Rev Endocr Metab Disord. 2008 Mar;9(1):21-31. doi: 10.1007/s11154-007-9062-0. Rev Endocr Metab Disord. 2008. PMID: 18163212 Review.

5

Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study.

Colao A, Auriemma RS, Galdiero M, Lombardi G, Pivonello R. Colao A, et al. Among authors: galdiero m. J Clin Endocrinol Metab. 2009 Oct;94(10):3746-56. doi: 10.1210/jc.2009-0941. Epub 2009 Jul 21. J Clin Endocrinol Metab. 2009. PMID: 19622615

6

Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly.

Auriemma RS, Grasso LF, Galdiero M, Galderisi M, Pivonello C, Simeoli C, De Martino MC, Ferrigno R, Negri M, de Angelis C, Pivonello R, Colao A. Auriemma RS, et al. Among authors: galdiero m. Endocrine. 2017 Mar;55(3):872-884. doi: 10.1007/s12020-016-0995-5. Epub 2016 Jun 13. Endocrine. 2017. PMID: 27295183

7

New perspectives in the medical treatment of acromegaly.

Colao A, Pivonello R, Auriemma RS, Galdiero M, Guerra E, Milone F, De Leo M, Lombardi G. Colao A, et al. Among authors: galdiero m. J Endocrinol Invest. 2005;28(11 Suppl International):58-66. J Endocrinol Invest. 2005. PMID: 16625847 Review.

8

A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients.

Colao A, Pivonello R, Spinelli L, Galderisi M, Auriemma RS, Galdiero M, Vitale G, De Leo M, Lombardi G. Colao A, et al. Among authors: galdiero m. J Endocrinol Invest. 2007 Jun;30(6):497-506. doi: 10.1007/BF03346334. J Endocrinol Invest. 2007. PMID: 17646725

9

Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: a retrospective, comparative, head-to-head study.

Auriemma RS, Pivonello R, Galdiero M, De Martino MC, De Leo M, Vitale G, Lombardi G, Colao A. Auriemma RS, et al. Among authors: galdiero m. J Endocrinol Invest. 2008 Nov;31(11):956-65. doi: 10.1007/BF03345632. J Endocrinol Invest. 2008. PMID: 19169050

10

Growth hormone, prolactin, and sexuality.

Galdiero M, Pivonello R, Grasso LF, Cozzolino A, Colao A. Galdiero M, et al. J Endocrinol Invest. 2012 Sep;35(8):782-94. doi: 10.1007/BF03345805. J Endocrinol Invest. 2012. PMID: 23014134 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

422 results

Search Page